Drug Trial Radar · NCT06861101
Phase II Study of JT002 in the Treatment of Seasonal Allergic Rhinitis in Adults
Last checked: Nov 19, 2026Latest source record: Jun 11, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
370
Actual
Start
Feb 24, 2025
Primary completion
May 6, 2025
Study completion May 14, 2025
Sponsor
- Lead sponsor
- Shanghai JunTop Biosciences Co., LTDIndustry
- Sponsor type
- Industry
- First posted
- Mar 6, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study included three phases: the treatment introduction period (4-7 days before randomization), the treatment period (14 days after randomization) and the follow-up period (7 days after the last dose). Eligible participants in this study entered the 4-7 day treatment introduction period. After completing the treatment introduction period, patients who did not meet the random exclusion criteria of this study were randomly assigned to one of the 4 dose cohorts in a 1:1:1:1 ratio, with 80 patients planned to be enrolled in each cohort, and then randomly assigned to receive the investigational product or placebo in the cohort at a 4:1 ratio, for a total of 320 patients. Participants were stratified by prior Drug therapy for Rhinitis allergic. Ultimately, the proportion of patients receiving 200 μg BID, 400 μg BID, 400 μg QD, 800 μg QD and placebo was 1:1:1:1:1 (64 patients in each group).
Conditions
- Seasonal Allergic Rhinitis
Interventions
JT002 Nasal sprayDrug
200 μg BID, 400 μg BID, 400 μg QD, 800 μg QD, 64 patients per cohort, total 256 patients for treatment 14 days
PlaceboDrug
Total 64 patients for treatment 14 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- rTNSSTime frame: During the 14-day treatment period
Locations
44 sites in 1 country. Site status is shown where the registry gives one.
Beijing Youan Hospital Capital Medical University
Beijing, Beijing Municipality, China
Peking University Third Hospital
Beijing, Beijing Municipality, China
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
The First Affiliated Hospital of Fujian Medical University
Fuzhou, Fujian, China
Wuwei People's Hospital
Wuwei, Gansu, China
Shenzhen Nanshan District People's Hospital
Shenzhen, Guangdong, China
Shenzhen University General Hospital
Shenzhen, Guangdong, China
Zhengzhou Central Hospital
Zhengzhou, Hanan, China
The Second Hospital of Baoding City
Baoding, Hebei, China
Cangzhou Central Hosptial
Cangzhou, Hebei, China
Hebei Retro China Central Hosptial
Hebei, Hebei, China
Hebei Provincial Hospital of Traditional Chinese Medicine
Shijiazhuang, Hebei, China
The Third Hospital of Hebei Medical University
Shijiazhuang, Hebei, China
The First Affiliated Hospital of Hebei North University
Zhangjiakou, Hebei, China
The People's Hospital of daqing
Daqing, Heilongjiang, China
The Fourth Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China
Jingzhou Central Hospital (Jingzhou Hospital affiliated to Yangtze University)
Jingzhou, Hubei, China
Wuhan Central Hospital
Wuhan, Hubei, China
Renmin Hospital of Wuhan University
Wuhan, Hubei, China
The Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
BaogangHospital of InnerMongolia
Baotou, InnerMongolia, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The First Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, China
Shengjing Hospital Affiliated to China Medical University
Shenyang, Liaoning, China
Liaoning Provincial Health Industry Group Iron Coal General Hospital
Tieling, Liaoning, China
Chifeng municipal hospital
Chifeng, Mongolia, China
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, Ningxia, China
The First People's Hospital of Yinchuan
Yinchuan, Ningxia, China
Zibo central hospital
Zibo, Shandong, China
Eye&Ent Hospital of fudan University
Shanghai, Shanghai Municipality, China
Shanghai Pudong Hospital, Fudan University Affiliated Pudong Medical Center
Shanghai, Shanghai Municipality, China
Heping hospital affiliated to Changzhi medical college
Changzhi, Shanxi, China
Second hospital of Shanxi Medical University
Taiyuan, Shanxi, China
First Hospital Of Shanxi Medical University
Taiyuan, Shanxi, China
Shanxi Bethune hospital
Taiyuan, Shanxi, China
The First Affiliated Hospital of Xi 'an Jiaotong University
Xi’an, Shanxi, China
The Second Affiliated Hospital of Xi 'an Jiaotong University
Xi’an, Shanxi, China
Xi'an DaXing Hospital
Xi’an, Shanxi, China
Xi'an High tech Hospital
Xi’an, Shanxi, China
Showing 40 of 44 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.